Does RITLECITINIB Cause Haemoglobin decreased? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Haemoglobin decreased have been filed in association with RITLECITINIB (Litfulo). This represents 0.4% of all adverse event reports for RITLECITINIB.
5
Reports of Haemoglobin decreased with RITLECITINIB
0.4%
of all RITLECITINIB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Haemoglobin decreased From RITLECITINIB?
Of the 5 reports, 1 (20.0%) required hospitalization.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITLECITINIB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does RITLECITINIB Cause?
Drug ineffective (259)
Therapeutic product effect incomplete (122)
Condition aggravated (85)
Off label use (82)
Headache (70)
Diarrhoea (49)
Product dose omission issue (45)
Alopecia (44)
Fatigue (36)
Urticaria (36)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which RITLECITINIB Alternatives Have Lower Haemoglobin decreased Risk?
RITLECITINIB vs RITODRINE
RITLECITINIB vs RITONAVIR
RITLECITINIB vs RITUXAN
RITLECITINIB vs RITUXIMAB
RITLECITINIB vs RITUXIMAB-ABBS